Small Interfering Ribonucleic Acid as Lipid-Lowering Therapy: Inclisiran in Focus.

Int J Mol Sci · 2023 · PMC10056056 · PMID 36983086

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Lastly, Lp(a) reduction over 180 days did not reach statistical significance, with a marked variability in single-dose groups (−14% to −18%) and in two-dose groups (−15% to −26%) [ 27 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.